NH

NantHealth
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.760
+0.050
+2.92%
Closed 16:00 09/23 EDT
OPEN
1.720
PREV CLOSE
1.710
HIGH
1.780
LOW
1.670
VOLUME
98.61K
TURNOVER
--
52 WEEK HIGH
6.60
52 WEEK LOW
1.560
MARKET CAP
202.76M
P/E (TTM)
-3.1867
1D
5D
1M
3M
1Y
5Y
NantHealth inks collaboration agreement with Intraprise Health
NantHealth (NH -3.1%) announces a collaboration with Intraprise Health, the provider of HIPAA One Security and Privacy Compliance software. HIPAA One’s Security Risk Assessment software will now be available to
Seekingalpha · 09/08 13:59
BRIEF-NantHealth, Intraprise Health Collaborate To Help Providers Meet HIPAA Compliance Requirements
reuters.com · 09/08 13:34
NantHealth and Intraprise Health Announce Collaboration to Help Providers Meet HIPAA Compliance Requirements and Protect Patient Data with HIPAA One Solution
NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced a collaboration with Intraprise Health, the provider of HIPAA One Security and Privacy Compliance softwa...
Business Wire · 09/08 13:00
Return on Capital Employed Overview: NantHealth
According to Benzinga Pro data, during Q2, NantHealth (NASDAQ:NH) posted sales of $16.09 million. Earnings were up 8.35%, but NantHealth still reported an overall loss of $8.59 million.
Benzinga · 09/02 15:30
NantHealth, Inc. (NH) Reports Q2 Loss, Lags Revenue Estimates
Zacks.com · 08/05 23:05
BRIEF-NantHealth Q2 Loss Per Share $0.13 From Continuing Operations
reuters.com · 08/05 21:03
NantHealth Reports 2021 Second Quarter Financial Results
CULVER CITY, Calif., August 05, 2021--NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its second quarter ended June 30, 2021.
Business Wire · 08/05 20:05
-- Earnings Flash (NH) NANTHEALTH Posts Q2 Revenue $16.1M, vs. Street Est of $16.6M
MT Newswires · 08/05 16:38
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NH. Analyze the recent business situations of NantHealth through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NH stock price target is 3.500 with a high estimate of 4.000 and a low estimate of 3.000.
EPS
Institutional Holdings
Institutions: 69
Institutional Holdings: 6.95M
% Owned: 6.03%
Shares Outstanding: 115.20M
TypeInstitutionsShares
Increased
10
658.32K
New
9
192.09K
Decreased
20
282.50K
Sold Out
8
188.02K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.62%
Healthcare Equipment & Supplies
+0.77%
Key Executives
Chairman/Chief Executive Officer/Founder/Director
Patrick Soon-Shiong
Chief Financial Officer/Chief Accounting Officer
Bob Petrou
Chief Operating Officer
Ronald Louks
Independent Director
Michael Blaszyk
Independent Director
Kirk Calhoun
Independent Director
Michael Sitrick
Independent Director
Deanna Wise
No Data
About NH
NantHealth, Inc.(NantHealth) is focused on developing technology that supports systems and data, enables efficiency, personalized treatment, and collaboration across health care. NantHealth is a provider and payers for software and devices that live at the intersection of precision medicine and value-based care. NantHealth's products include Eviti, NaviNet, and OpenNMS. Eviti is a decision support platform that provides evidence-based clinical decision support. NaviNet is a payer-provider collaboration platform a secure, multi-payer Web portal that lets payers and providers exchange administrative and clinical information in real-time. OpenNMS, which is an open-source network monitoring solution for enterprise-grade networks. Its solutions include data management, analysis and interpretation solutions, network monitoring, software-as-a-service platforms, and molecular profiling solutions, enabling value-based care and evidence-based clinical practice.

Webull offers kinds of NantHealth Inc stock information, including NASDAQ:NH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NH stock methods without spending real money on the virtual paper trading platform.